KMT2A and acute myeloid leukemia: In the MLL-AF9 acute myeloid leukemia (AML) in vivo model, it has been shown that CSCs express periostin and its receptor, integrin, in secondary target tissues indicating the autocrine and paracrine effects of periostin on CSCs behavior such as invasion and metastasis [147].